Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 107980
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.107980
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.107980
Table 5 Comparison of features between the training and validation sets, n (%)
Characteristic | Test (n = 78) | Train (n = 182) | χ2 | P value |
Age, years | 0.80 | 0.370 | ||
< 60 | 39 (50.00) | 80 (43.96) | ||
≥ 60 | 39 (50.00) | 102 (56.04) | ||
Sex | 0.21 | 0.645 | ||
Female | 37 (47.44) | 92 (50.55) | ||
Male | 41 (52.56) | 90 (49.45) | ||
BMI, kg/m2 | 0.21 | 0.054 | ||
< 25 | 66 (84.62) | 134 (73.63) | ||
≥ 25 | 12 (15.38) | 48 (26.37) | ||
FAR | 0.62 | 0.432 | ||
Low | 34 (43.59) | 89 (48.90) | ||
High | 44 (56.41) | 93 (51.10) | ||
ECOG | 0.21 | 0.647 | ||
0 | 50 (64.10) | 122 (67.03) | ||
1 | 28 (35.90) | 60 (32.97) | ||
Site | 0.87 | 0.350 | ||
Stomach | 42 (53.85) | 86 (47.25) | ||
Gastric and esophageal binding | 36 (46.15) | 96 (52.75) | ||
Histological | 1.74 | 0.188 | ||
Adenocarcinoma | 25 (32.05) | 44 (24.18) | ||
Other | 53 (67.95) | 138 (75.82) | ||
Staging | 0.77 | 0.379 | ||
3 | 27 (36.62) | 53 (29.12) | ||
4 | 51 (65.38) | 129 (70.88) | ||
CEA, ng/mL | 3.60 | 0.058 | ||
< 3 | 39 (50.00) | 68 (37.36) | ||
≥ 3 | 39 (50.00) | 114 (62.64) | ||
Liver metastasis | 0.59 | 0.441 | ||
No | 54 (69.23) | 114 (64.29) | ||
Yes | 24 (30.77) | 68 (37.36) | ||
Peritoneal metastasis | 1.04 | 0.308 | ||
No | 61 (78.21) | 152 (83.52) | ||
Yes | 17 (21.97) | 30 (16.48) | ||
EBV status | 0.00 | 0.971 | ||
No-infect | 65 (83.33) | 152 (83.52) | ||
Infect | 13 (16.67) | 30 (16.48) | ||
PD-L1 expression | 0.29 | 0.588 | ||
CPS < 5 | 14 (17.95) | 38 (4.40) | ||
CPS ≥ 5 | 64 (82.05) | 174 (95.60) | ||
MMR status | 0.00 | 1.000 | ||
pMMR | 4 (5.13) | 8 (4.40) | ||
dMMR | 74 (94.87) | 174 (95.60) |
- Citation: Yao ZY, Liu J, Ma X, Li WT, Shen Y, Cui YZ, Fang Y, Han ZX, Yang CH. Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy. World J Gastrointest Oncol 2025; 17(6): 107980
- URL: https://www.wjgnet.com/1948-5204/full/v17/i6/107980.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.107980